ClearPoint Neuro Inc vs NEOS S&P 500 High Income ETF — how do they compare? ClearPoint Neuro Inc trades at $15.17 (market cap $454.21M), while NEOS S&P 500 High Income ETF trades at $54.23. The key difference: NEOS S&P 500 High Income ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | SPYI | |
|---|---|---|
Market Cap | $454.21M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $29.60 | $54.19 |
52-Week Low | $8.66 | $47.98 |
Enterprise Value | $488.79M | — |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $15.20, up 4.32% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings estimates, with a net income margin of -81.76%. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology.
The outlook remains speculative with high growth potential in neurotherapy markets, but significant execution and profitability risks persist. Analyst consensus is unanimously bullish, though sustained losses and cash burn require careful monitoring for long-term investors.
SPYI trades at $54.23, up 0.07% on the day, with a bullish technical signal driven by moving averages. The ETF focuses on generating high income through an options overlay on the S&P 500, offering a distribution yield near 12%. Recent news highlights its appeal for retirement income but raises concerns about fee gaps and potential over-reliance on volatility for payouts.
The outlook is mixed: SPYI provides tax-efficient yield for income investors but faces risks from declining volatility and capital erosion. Wall Street debates sustainability, with some analysts bullish on its strategy while others warn of hidden costs. Investors should weigh high distributions against long-term principal preservation.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →